Decreased frontal white-matter integrity in abstinent methamphetamine abusers

International Journal of Neuropsychopharmacology

Volumn 10, Issue 6, 2007, Pages 765-775

  Chung, Ain ^a,b   Lyoo, In Kyoon ^a,b,c,e   Kim, Seog Ju ^d   Hwang, Jaeuk ^a   Bae, Soojeong C ^a,b   Sung, Young Hoon ^a   Sim, Minyoung E ^a   Song, In Chan ^a   Kim, Jihyun ^a   Chang, Kee Hyun ^a   Renshaw, Perry F ^c  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University   (South Korea)

^c MCLEAN HOSPITAL   (United States)

^d Gachon University College of Medicine   (South Korea)

^e Seoul National University Hospital   (South Korea)

Author keywords

Diffusion tensor; Frontal lobe; Methamphetamine; White matter

Indexed keywords

METHAMPHETAMINE;

ADULT; ANALYTICAL ERROR; ANISOTROPY; ANTERIOR COMMISSURE; ARTICLE; BRAIN COMMISSURE; BRAIN FUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFUSION TENSOR IMAGING; DRUG ABUSE; DRUG WITHDRAWAL; FEMALE; FRONTAL CORTEX; HUMAN; MALE; NEUROTOXICITY; PERSEVERATION; PRIORITY JOURNAL; SEX DIFFERENCE; WHITE MATTER; WISCONSIN CARD SORTING TEST;

ADULT; AMPHETAMINE-RELATED DISORDERS; ANISOTROPY; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; METHAMPHETAMINE; NEUROPSYCHOLOGICAL TESTS; PREFRONTAL CORTEX; PSYCHIATRIC STATUS RATING SCALES; SEX CHARACTERISTICS; SUBSTANCE ABUSE DETECTION;

EID: 35649019691     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145706007395     Document Type: Article

References (36)

1. Alberson DN, Pruetz B, Schmidt CJ, Khun DM, Kapatos G, Bannon MJ (2004). Gene expression profile of the nucleus accumbens of human cocaine abusers: evidence for dysregulation of myelin. Journal of Neurochemistry 88, 1211-1219.
2. Bae SC, Lyoo IK, Sung YH, Yoo J, Chung A, Yoon SJ, Kim DJ, Hwang J, Kim SJ, Renshaw PF (2006). Increased white matter hyperintensities in male methamphetamine abusers. Drug and Alcohol Dependence 81, 83-88.
3. Basser PJ (1995). Inferring microstructural features and the physiological state of tissues from diffusion-weighted images. NMR in Biomedicine 8, 333-344.
4. Chang L, Ernst T, Speck O, Patel H, DeSilva M, Leonido-Yee M, Miller EN (2002). Perfusion MRI and computerized cognitive test abnormalities in abstinent methamphetamine users. Psychiatry Research 114, 65-79.
5. Chang L, Ernst T, Strickland T, Mehringer CM (1999). Gender effects on persistent cerebral metabolite changes in the frontal lobes of abstinent cocaine users. American Journal of Psychiatry 156, 716-722.
6. Culmsee C, Vedder H, Ravati A, Junker V, Otto D, Ahlemeyer B, Krieg JC, Krieglstein J (1999). Neuroprotection by estrogens in a mouse model of focal cerebral ischemia and in cultured neurons: evidence for a receptor-independent antioxidative mechanism. Journal of Cerebral Blood Flow and Metabolism 19, 1263-1269.
7. Deng X, Wang Y, Chou J, Cadet JL (2001). Methamphetamine causes wide spread apoptosis in the mouse brain : evidence from using an improved TUNEL histochemical method. Brain Research. Molecular Brain Research 93, 64-69.
8. Dluzen DE, Anderson LI, Pilati CF (2002). Methamphetamine-gonadal steroid hormonal interactions: effects upon acute toxicity and striatal dopamine concentrations. Neurotoxicology and Teratology 24, 267-273.
9. Dluzen DE, McDermott JL (2002). Estrogen, anti-estrogen, and gender: differences in methamphetamine neurotoxicity. Annals of the New York Academy of Science 965, 136-156.
10. Dluzen DE, Tweed C, Anderson LI, Laping NJ (2003). Gender differences in methamphetamine-induced mRNA associated with neurodegeneration in the mouse nigrostriatal dopaminergic system. Neuroendocrinology 77, 232-238.
11. Ernst T, Chang L, Leonido-Yee M, Speck O (2000a). Evidence for long-term neurotoxicity associated with methamphetamine abuse: A 1H MRS study. Neurology 54, 1344-1349.
12. Ernst T, Chang L, Oropilla G, Gustavson A, Speck O (2000b). Cerebral perfusion abnormalities in abstinent cocaine abusers: a perfusion MRI and SPECT study. Psychiatry Research 99, 63-74.
13. Gao X, Dluzen DE (2001). The effect of testosterone upon methamphetamine neurotoxicity of the nigrostriatal dopaminergic system. Brain Research 892, 63-69.
14. Garcia-Segura LM, Naftolin F, Hutchison JB, Azcoitia I, Chowen JA (1999). Role of astroglia in estrogen regulation of synaptic plasticity and brain repair. Journal of Neurobiology 40, 574-584.
15. Goldstein RZ, Volkow ND, Chang L, Wang GJ, Fowler JS, Depue RA, Gur RC (2002). The orbitofrontal cortex in methamphetamine addiction : involvement in fear. Neuroreport 13, 2253-2257.
16. Hirata H, Ladenheim B, Carlson E, Epstein C, Cadet JL (1996). Autoradiographic evidence for methamphetamine-induced striatal dopaminergic loss in mouse brain : attenuation in CuZn-superoxide dismutase transgenic mice. Brain Research 714, 95-103.
17. Kalechstein AD, Newton TF, Green M (2003). Methamphetamine dependence is associated with neurocognitive impairment in the initial phases of abstinence. Journal of Neuropsychiatry and Clinical Neuroscience 15, 215-220.
18. Kim JM, Cho GJ, Hong SK, Chang KH, Chung JS, Choi YH, Song YG, Huh A, Yeom JS, Lee KS, Choi JY (2003). Epidemiology and clinical features of HIV infection/AIDS in Korea. Yonsei Medical Journal 44, 363-370.
19. Kim SJ, Lyoo IK, Hwang J, Chung A, Hoon Sung Y, Kim J, Kwon DH, Chang KH, Renshaw PF (2006). Prefrontal grey-matter changes in short-term and long-term abstinent methamphetamine abusers. International Journal of Neuropsychopharmacology 9, 221-228.
20. Kim SJ, Lyoo IK, Hwang J, Sung YH, Lee HY, Lee DS, Jeong DU, Renshaw PF (2005). Frontal glucose hypometabolism in abstinent methamphetamine users. Neuropsychopharmacology 30, 1383-1391.
21. Lim KO, Choi SJ, Pomara N, Wolkin A, Rotrosen JP (2002). Reduced frontal white matter integrity in cocaine dependence: a controlled diffusion tensor imaging study. Biological Psychiatry 51, 890-895.
22. Melo P, Moreno VZ, Vazquez SP, Pinazo-Duran MD, Tavares MA (2006). Myelination changes in the rat optic nerve after prenatal exposure to methamphetamine. Brain Research 1106, 21-29.
23. Mermelstein PG, Becker JB, Surmeier DJ (1996). Estradiol reduces calcium currents in rat neostriatal neurons via a membrane receptor. Journal of Neuroscience 16, 595-604.
24. Oakes TR, Johnstone T, Ores Walsh KS, Greischar LL, Alexander AL, Fox AS, Davidson RJ (2005). Comparison of fMRI motion correction software tools. Neuroimage 28, 529-543.
25. Paganini-Hill A, Ross RK, Henderson BE (1988). Postmenopausal oestrogen treatment and stroke : a prospective study. British Medical Journal 297, 519-522.
26. Paulus MP, Hozack N, Frank L, Brown GG, Schuckit MA (2003). Decision making by methamphetamine-dependent subjects is associated with error-rate-independent decrease in prefrontal and parietal activation. Biological Psychiatry 53, 65-74.
27. Paulus MP, Hozack NE, Zauscher BE, Frank L, Brown GG, Braff DL, Schuckit MA (2002). Behavioral and functional neuroimaging evidence for prefrontal dysfunction in methamphetamine-dependent subjects. Neuropsychopharmacology 26, 53-63.
28. Pfefferbaum A, Sullivan EV (2002). Microstructural but not macrostructural disruption of white matter in women with chronic alcoholism. Neuroimage 15, 708-718.
29. Robinson AL, Heaton RK, Lehman RA, Stilson DW (1980). The utility of the Wisconsin Card Sorting Test in detecting and localizing frontal lobe lesions. Journal of Consulting and Clinical Psychology 48, 605-614.
30. Sawada H, Ibi M, Kihara T, Urushitani M, Akaike A, Kimura J, Shimohama S (1998). Dopamine D2-type agonists protect mesencephalic neurons from glutamate neurotoxicity: mechanisms of neuroprotective treatment against oxidative stress. Annals of Neurology 44, 110-119.
31. Sekine Y, Minabe Y, Ouchi Y, Takei N, Iyo M, Nakamura K, Suzuki K, Tsukada H, Okada H, Yoshikawa E, et al. (2003). Association of dopamine transporter loss in the orbitofrontal and dorsolateral prefrontal cortices with methamphetamine-related psychiatric symptoms. American Journal of Psychiatry 160, 1699-1701.
32. Sulzer D, Chen TK, Lau YY, Kristensen H, Rayport S, Ewing A (1995). Amphetamine redistribute dopamine from synaptic vesicles to the cytosol and promotes reverse transport. Journal of Neuroscience 15, 4102-4108.
33. Volkow ND, Chang L, Wang GJ, Fowler JS, Ding YS, Sedler M, Logan J, Franceschi D, Gatley J, Hitzemann R, et al. (2001). Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex. American Journal of Psychiatry 158, 2015-2021.
34. Vorhees CV, Ahrens KG, Acuff-Smith KD, Schilling MA, Fisher JE (1994). Methamphetamine exposure during early postnatal development in rats : I. Acoustic startle augmentation and spatial learning deficits. Psychopharmacology (Berlin) 114, 392-401.
35. Wagner GC, Tekirian TL, Cheo CT (1993). Sexual differences in sensitivity to methamphetamine toxicity. Journal of Neural Transmission 93, 67-70.
36. Wirz-Justice A, Hackmann E, Lichtsteiner M (1974). The effect of oestradiol dipropionate and progesterone on monoamine uptake in rat brain. Journal of Neurochemistry 22, 187-189.